Champions for Longevity (C4L) brings together current and former athletes to champion policies that promote healthy aging and longevity science.
Champions for Longevity (C4L) is a nonprofit initiative that unites retired and current professional athletes to advance longevity research. C4L serves as a platform for athletes to advocate for science-backed strategies that promote vitality, resilience, and extended healthspan.
Athletes bring lived experience with early-onset joint deterioration, cognitive strain, and accelerated physical wear. They are uniquely positioned to raise awareness, support rigorous research, and elevate public trust in longevity science.
C4L is committed to:
Driving investment into athlete-centered studies
Collaborating with world-class scientists and institutions
Making clinical data transparent and publicly accessible
Translating scientific progress into actionable policy and practice
This initiative is designed to not only serve athletes, but to help everyone benefit from evidence-based approaches to living longer, healthier lives.
Professional athletes often experience the effects of physical decline earlier than the general population due to intense training, competition, and injury. These firsthand experiences with reduced mobility, cognitive challenges, and chronic pain offer a human-centered lens through which to understand the long-term consequences of biological wear and tear.
Champions for Longevity (C4L) recognizes that athletes are uniquely positioned to raise awareness around the importance of longevity research. Their voices resonate with diverse audiences—from fans and families to policymakers and funders—making them powerful advocates for a future where science helps us preserve vitality and extend healthy years of life.
This perspective is rooted in data. Across major sports, former athletes consistently experience higher rates of musculoskeletal and cognitive decline compared to their peers:
These outcomes aren’t just statistics—they’re a call to action. Athletes know better than anyone that performance declines are not theoretical. They live the consequences of joint deterioration, cognitive changes, and long recoveries. Their experiences are not anomalies, they are concentrated examples of challenges millions of Americans will face as they age.
By amplifying the voices of athletes and pairing them with the tools of longevity science, Champions for Longevity (C4L) is committed to translating this lived experience into measurable progress—advancing research, guiding funding, and accelerating access to interventions that preserve both function and quality of life.
Assist in securing financial support for longevity research initiatives focused on athlete health and performance.
Utilize their platforms to raise public awareness about the importance of extending healthy lifespan through longevity science.
Partner with scientists and research institutions to validate and promote the efficacy of emerging longevity therapies.
Publicly share the results of funded studies to inform stakeholders and the general public.
Translate research findings into actionable initiatives and policy recommendations to promote equitable access to longevity treatments.
Phase 1: Fundraising
Raise $25 million for pilot studies focusing on:
Performance and vitality in retired athletes
Rejuvenation therapies for injured athletes
Cognitive health interventions for athletes from combat sports
Phase 2: Open-Call
Issue an open call for research proposals from scientists and institutions interested in athlete-focused longevity studies.
Phase 3: Initiation
Recruit participants and initiate research studies in collaboration with selected research partners.
Phase 4: Publication
Publicize and share study results through various channels to inform policy, practice, and public understanding.
For additional information about the Longevity Athlete’s Commission or to explore opportunities for collaboration, please contact us at info@a4li.org.
The Alliance for Longevity Initiatives (A4LI) is a 501(c)(4) nonprofit organization whose mission is to advance legislation and policies that aim to increase healthy human lifespan, with a focus on accelerating equitable access to next-generation therapies.
